Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-21
    E.g., 2018-09-21

Archive Search

2 results
12:00 AM, Oct 08, 2012  |  BioCentury | Product Development

Contrarian thinking

GRM5 ) in Phase IIb testing for treatment-resistant depression. RG1578 is a negative modulator of mGluR2
of monoamine oxidase B (MAO-B) AD Ph II pRED/Evotec AG (Xetra:EVT) RG1578 Negative modulator of mGluR2/3 …
12:00 AM, Dec 10, 2007  |  BioCentury | Product Development

Modifying Parkinson's

is in preclinical testing for osteoporosis and contraception. ADXN also has positive allosteric modulators of mGluR2